Search Within

Shigeki Shimizu

Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Department of Pathology and Laboratory Medicine (11)
  2. GSK Faculty (9)
  3. Human Oncology and Pathogenesis Program (9)
  4. Surgery (9)
  5. Tow Center for Developmental Oncology (TCDO) (9)
  6. Sloan Kettering Institute Postdocs (2)

More Groups

People
  1. Marc Ladanyi (9)
  2. Valerie Rusch (9)
  3. Adam Olshen (8)
  4. Marie Brevet (4)
  5. Maureen Zakowski (4)
  6. Qin Zhou (4)

More People

Years
  1. 2011 (2)
  2. 2010 (4)
  3. 2007 (2)
  4. 2006 (3)
Publications
  1. Journal of Clinical Oncology (2)
  2. Lung Cancer (2)
  3. Cancer Research (1)
  4. Clinical Cancer Research (1)
  5. Histopathology (1)
  6. Journal of Thoracic Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Ireland Ltd. (2)
  4. Nature Publishing Group (2)
  5. Elsevier Inc. (1)
  6. Nature Research (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
    Journal Article

    Bott, M.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Wang, L.; Creaney, J.; Lake, R. A.; Zakowski, M. F.; Reva, B.; more...
    Nature Genetics (2011)

    Fulltext@MSK | Save
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy
    Journal Article

    Brevet, M.; Shimizu, S.; Bott, M. J.; Shukla, N.; Zhou, Q.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Use of integrated genomic analysis to evaluate BRCA-associated protein 1 (BAP1) as a mutated gene in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Bott, M. J.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Zhou, Q.; Olshen, A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Effect of EGFR and IGF1R on feedback activation of AKT arising from inhibition of mTOR in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Brevet, M.; Shimizu, S.; Zhou, Q.; Olshen, A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer
    Journal Article

    Yoshizawa, A.; Fukuoka, J.; Shimizu, S.; Shilo, K.; Franks, T. J.; Hewitt, S. M.; Fujii, T.; Cordon-Cardo, C.; Jen, J.; Travis, W. D.
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Peripheral pulmonary papillary/glandular neoplasms with ciliated cells and a component of well-differentiated adenocarcinoma: Report of three tumours
    Journal Article

    Arai, Y.; Shimizu, S.; Eimoto, T.; Ichi Shimizu, S.; Otsuki, Y.; Kobayashi, H.; Ogawa, H.; Travis, W. D.
    Histopathology (2010)

    Fulltext@MSK | Save
  • MET in pleural mesothelioma: Mutational screening, phosphorylation status, and sensitivity to MET inhibition
    Meeting Abstract

    Shimizu, S.; Lopez-Rios, F.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • MET in pleural mesothelioma: Mutational screening, phosphorylation status, and sensitivity to MET inhibition
    Meeting Abstract

    Shimizu, S.; Lopez-Rios, F.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • An integrated genomic approach to understanding the determinants of mesotheliorna sensitivity to specific novel agents
    Meeting Abstract

    Shimizu, S.; Olshen, A. B.; Krug, L.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • MET in mesothelioma: Mutational screening, phosphorylation status, and sensitivity to the MET inhibitor PHA-665752
    Meeting Abstract

    Shimizu, S.; Krug, L.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save